GILEAD SCIENCES, INC. (GILD) Financials
Annual revenue, profitability and per-share results for GILEAD SCIENCES, INC., as reported in SEC filings.
Revenue • FY2025
$29.44B
▲ 2.4%YoY
Net income • FY2025
$8.51B
▲ 1672.9%YoY
Gross margin • FY2025
78.8%
Diluted EPS • FY2025
$6.78
▲ 1684.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $29.44B | $8.51B | $23.21B | $6.78 | $9.46B | 34.0% | +2.4% |
| FY2024 | $28.75B | $480M | $22.5B | $0.38 | $10.3B | 5.8% | +6.0% |
| FY2023 | $27.12B | $5.67B | $20.62B | $4.50 | $7.42B | 28.1% | -0.6% |
| FY2022 | $27.28B | $4.59B | $21.62B | $3.64 | $8.34B | 26.9% | -0.1% |
Figures as reported in GILEAD SCIENCES, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to GILD
Never miss a GILD filing.
Get an email when GILD files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.